Global Coronary Embolic Protection Device 麻豆原创 Report 2018-2029

Publication ID:

HJR06230032

Publication Date:

June 29, 2023

Pages:

149

Publisher:

HJResearch

Countries:

Global [1]

USD 3,200.00

Medical Devices [2]

Pharmaceutical Manufacturing [3]

Pharma & Healthcare [4]

Description:

Coronary Embolic Protection Device (CEPD) is a medical device used during cardiovascular, neurovascular and peripheral procedures to filter and capture embolic debris that can be dislodged during the intervention. The device is designed to prevent embolic debris such as blood clots, plaque, or other foreign material from traveling downstream and causing blockages in smaller blood vessels.

The global Coronary Embolic Protection Device market size in 2022 is projected to be US$1141.37 million, with a compound annual growth rate of 8.77%. This growth is driven by an increasing prevalence of cardiovascular diseases coupled with advancements in medical technology and the rising demand for minimally invasive procedures.

Cardiovascular, neurovascular and peripheral procedures are the primary applications of Coronary Embolic Protection Devices. These devices are widely adopted in coronary artery bypass grafting, carotid artery stent placement, and peripheral artery interventions. The use of CEPD has been shown to reduce the risk of cerebral embolization during these procedures, leading to improved patient outcomes.

Boston Scientific, Medtronic, Abbott, Cordis, Allium Medical, Contego Medical, W.L. Gore & Associates, Silk Road Medical, Claret Medical, and AngioSlide are the major global manufacturers of CEPD. These companies invest heavily in research and development to improve the effectiveness and safety of their products, expand their market share, and drive innovation in the industry.

The Coronary Embolic Protection Device industry's future prospects appear positive, given the continued growth in demand for minimally invasive procedures and the rising prevalence of cardiovascular diseases worldwide. However, the industry also faces challenges such as increasing competition from alternative treatments, regulatory requirements that can lead to delays in product development and approval, and economic downturns that may impact market growth in some regions.

In conclusion, Coronary Embolic Protection Device is a medical device used during cardiovascular, neurovascular and peripheral procedures to filter and capture embolic debris. The global market for Coronary Embolic Protection Device is expected to grow in the coming years, driven by the increasing prevalence of cardiovascular diseases, advancements in medical technology, and the rising demand for minimally invasive procedures. Major global manufacturers will continue to invest in research and development to improve the effectiveness and safety of their products, expand their market share, and drive innovation in the industry.

The SWOT analysis of the Coronary Embolic Protection Device industry is as follows:

Strengths:
Coronary Embolic Protection Devices provide an effective solution for reducing the risk of embolic debris traveling downstream and causing blockages in smaller blood vessels during cardiovascular, neurovascular and peripheral procedures.
The global Coronary Embolic Protection Device market size is projected to grow at a compound annual growth rate of 8.77%, driven by the increasing prevalence of cardiovascular diseases, advancements in medical technology, and the rising demand for minimally invasive procedures.
Key industry players invest heavily in research and development to improve the effectiveness and safety of their products, expand their market share, and drive innovation in the industry.

Weaknesses:
Coronary Embolic Protection Devices are typically invasive procedures that carry some risks, including bleeding, infection, and stroke, which can limit their use in certain patients.
High costs associated with the procedure can limit access for patients in lower-income countries or those without adequate health insurance coverage.

Opportunities:
The continued growth of emerging markets presents an opportunity for Coronary Embolic Protection Device manufacturers to expand their market presence and increase sales in regions with high rates of cardiovascular disease.
Technological advancements in medical devices, such as robot-assisted procedures and minimally invasive surgery, could potentially improve the safety and effectiveness of Coronary Embolic Protection Devices, driving increased adoption rates and market growth.
Strategic partnerships with healthcare providers and research institutions could lead to the development of new applications for Coronary Embolic Protection Devices, improving patient outcomes and enhancing the market position of industry players.

Threats:
The Coronary Embolic Protection Device industry faces increasing competition from alternative treatments for cardiovascular disease, such as drug-eluting stents and bypass surgeries.
Regulatory requirements for medical devices can be complex and lengthy, leading to delays in product development and approval, which can increase costs and limit market opportunities.
Economic downturns and geopolitical instability could impact market growth in some regions, potentially limiting demand for Coronary Embolic Protection Devices.

Key players in global Coronary Embolic Protection Device market include:
Boston Scientific
Medtronic
Abbott
Cordis
Allium Medical
Contego Medical
W.L. Gore & Associates
Silk Road Medical
Claret Medical
AngioSlide

麻豆原创 segmentation, by product types:
Nitinol
Polyurethane

麻豆原创 segmentation, by applications:
Cardiovascular
Neurovascular
Peripheral

Table Of Contents:

1 Industry Overview of Coronary Embolic Protection Device
1.1 Research Scope
1.2 麻豆原创 Segmentation by Types of Coronary Embolic Protection Device
1.3 麻豆原创 Segmentation by End Users of Coronary Embolic Protection Device
1.4 麻豆原创 Dynamics Analysis of Coronary Embolic Protection Device
1.4.1 麻豆原创 Drivers
1.4.2 麻豆原创 Challenges
1.4.3 麻豆原创 Opportunities
1.4.4 Porter鈥檚 Five Forces

2 Major Manufacturers Analysis of Coronary Embolic Protection Device Industry
2.1 Boston Scientific
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Medtronic
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Abbott
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Cordis
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 Allium Medical
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Contego Medical
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 W.L. Gore & Associates
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Silk Road Medical
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Claret Medical
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 AngioSlide
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Coronary Embolic Protection Device Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.10.4 Contact Information

3 Global Coronary Embolic Protection Device 麻豆原创 Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Volume and Revenue of Coronary Embolic Protection Device by Regions (2018-2023)
3.2 Global Sales Volume and Revenue of Coronary Embolic Protection Device by Manufacturers (2018-2023)
3.3 Global Sales Volume and Revenue of Coronary Embolic Protection Device by Types (2018-2023)
3.4 Global Sales Volume and Revenue of Coronary Embolic Protection Device by End Users (2018-2023)
3.5 Selling Price Analysis of Coronary Embolic Protection Device by Regions, Manufacturers, Types and End Users in (2018-2023)

4 Northern America Coronary Embolic Protection Device 麻豆原创 Analysis by Countries, Types and End Users
4.1 Northern America Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Countries (2018-2023)
4.2 Northern America Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Types (2018-2023)
4.3 Northern America Coronary Embolic Protection Device Sales Volume and Revenue Analysis by End Users (2018-2023)
4.4 United States Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
4.5 Canada Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)

5 Europe Coronary Embolic Protection Device 麻豆原创 Analysis by Countries, Types and End Users
5.1 Europe Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Countries (2018-2023)
5.2 Europe Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Types (2018-2023)
5.3 Europe Coronary Embolic Protection Device Sales Volume and Revenue Analysis by End Users (2018-2023)
5.4 Germany Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.5 France Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.6 UK Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.7 Italy Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.8 Russia Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.9 Spain Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.10 Netherlands Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)

6 Asia Pacific Coronary Embolic Protection Device 麻豆原创 Analysis by Countries, Types and End Users
6.1 Asia Pacific Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Coronary Embolic Protection Device Sales Volume and Revenue Analysis by End Users (2018-2023)
6.4 China Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.5 Japan Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.6 Korea Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.7 India Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.8 Australia Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.9 Indonesia Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.10 Vietnam Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)

7 Latin America Coronary Embolic Protection Device 麻豆原创 Analysis by Countries, Types and End Users
7.1 Latin America Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Countries (2018-2023)
7.2 Latin America Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Types (2018-2023)
7.3 Latin America Coronary Embolic Protection Device Sales Volume and Revenue Analysis by End Users (2018-2023)
7.4 Brazil Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.5 Mexico Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.6 Argentina Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.7 Colombia Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)

8 Middle East & Africa Coronary Embolic Protection Device 麻豆原创 Analysis by Countries, Types and End Users
8.1 Middle East & Africa Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Coronary Embolic Protection Device Sales Volume and Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Coronary Embolic Protection Device Sales Volume and Revenue Analysis by End Users (2018-2023)
8.4 Turkey Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.5 Saudi Arabia Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.6 South Africa Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.7 Egypt Coronary Embolic Protection Device Sales Volume, Revenue, Import and Export Analysis (2018-2023)

9 麻豆原创ing Channel, Distributors and Traders Analysis
9.1 麻豆原创ing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders

10 Global Coronary Embolic Protection Device 麻豆原创 Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Volume and Revenue Forecast of Coronary Embolic Protection Device by Regions (2024-2029)
10.2 Global Sales Volume and Revenue Forecast of Coronary Embolic Protection Device by Types (2024-2029)
10.3 Global Sales Volume and Revenue Forecast of Coronary Embolic Protection Device by End Users (2024-2029)
10.4 Global Revenue Forecast of Coronary Embolic Protection Device by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)

11 Industry Chain Analysis of Coronary Embolic Protection Device
11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Coronary Embolic Protection Device
11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Coronary Embolic Protection Device
11.1.2 Major Equipment Suppliers with Contact Information Analysis of Coronary Embolic Protection Device
11.2 Downstream Major Consumers Analysis of Coronary Embolic Protection Device
11.3 Major Suppliers of Coronary Embolic Protection Device with Contact Information
11.4 Supply Chain Relationship Analysis of Coronary Embolic Protection Device

12 Coronary Embolic Protection Device New Project Investment Feasibility Analysis
12.1 Coronary Embolic Protection Device New Project SWOT Analysis
12.2 Coronary Embolic Protection Device New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule

13 Coronary Embolic Protection Device Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.